GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Compugen Ltd. stock after losing 1.05%
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.05% PDF

The Compugen Ltd. stock price fell by -1.05% on the last day (Thursday, 18th Apr 2024) from $1.90 to $1.88. During the last trading day the stock fluctuated 7.10% from a day low at $1.83 to a day high of $1.96. The price has fallen in 6 of the last 10 days and is down by -18.97% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -63 thousand shares and in total, 309 thousand shares were bought and sold for approximately $580.63 thousand.

Given the current short-term trend, the stock is expected to rise 5.95% during the next 3 months and, with a 90% probability hold a price between $1.99 and $3.22 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CGEN Signals & Forecast

There are few to no technical positive signals at the moment. The Compugen Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.06 and $2.49. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 04, 2024, and so far it has fallen -36.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Compugen Ltd. stock

Compugen Ltd. finds support from accumulated volume at $1.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 7.10%. For the last week the stock has had daily average volatility of 8.53%.

Compugen Ltd. is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CGEN) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Compugen Ltd. to open at $1.89, and during the day (based on 14 day Average True Range), to move between $1.73 and $2.03, which gives a possible trading interval of +/-$0.154 (+/-8.19%) up or down from last closing price. If Compugen Ltd. takes out the full calculated possible swing range there will be an estimated 16.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.87 (0.53%) than the resistance at $2.11 (12.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Compugen Ltd. stock A Buy?

The Compugen Ltd. stock holds several negative signals and despite the positive trend, we believe Compugen Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.458 Sell Candidate Unchanged

Predicted Opening Price for Compugen Ltd. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.89 ( 0.534%) $1.88

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.02 7.44 %
R2 1.97 4.80 %
R1 1.94 3.17 %
Current price: 1.88
Support S1 1.84 -2.11 %
S2 1.81 -3.74 %
S3 1.76 -6.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.32 23.40 %
R2 2.21 17.55 %
R1 2.11 12.23 %
Current price 1.88
Support S1 1.87 -0.532%
S2 1.86 -1.06%
S3 0 .

FAQ

What is the symbol for Compugen Ltd. Stock and on which exchange is it traded?
The symbol for Compugen Ltd. is CGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Compugen Ltd. Stock?
The Compugen Ltd. stock holds several negative signals and despite the positive trend, we believe Compugen Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Compugen Ltd. Stock?
Compugen Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Compugen Ltd. Stock.

What's the current price of Compugen Ltd. Stock?
As of the end of day on the 2024-04-18, the price of an Compugen Ltd. (CGEN) share was $1.88.

What is the 52-week high and low for Compugen Ltd. Stock?
The 52-week high for Compugen Ltd. Stock is $3.03 and the 52-week low is $0.530.

What is the market capitalization of Compugen Ltd. Stock?
As of the 2024-04-18, the market capitalization of Compugen Ltd. is 170.107M.

When is the next earnings date for Compugen Ltd.?
The upcoming earnings date for Compugen Ltd. is May 20, 2024.
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT